21 cytokines differed considerably between STEMI patients and healthy controls.
BNDF, PDGF-AA and MMP-9 were clinically validated increase in AMI patients.
These three cytokines showed 80%, 90%, and 100% in specificity with the sensitivity ranging between 70% and 80%.
These three cytokines represented up-regulation in AMI samples, and may hold promise for the assessment of AMI.